Prof. Dr. med.
Manuela
Albisetti Pedroni
2017: Adjunct Professor of the University of Zurich, Switzerland
2008: Venia legendi für das Gebiet der Pädiatrie, speziell Hämostaseologie, Medizinischen Fakultät der Universität Zürich, Zürich mit dem Titel «Arterial thrombosis in childhood: specific aspects of fibrinolytic system and therapy»
1995: Swiss Boards in Paediatrics (FMH)
1991: Medical Doctor Degree with the dissertation «Symptome, Diagnose and Therapie des Meckel’schen Divertikels», University of Zurich, Switzerland
1989: Physician Degree, University of Zurich, Switzerland
2000-2001: «Research fellow», The Hospital for Sick Children, Paediatric Thrombophilia Program, Division of Haematology/Oncology, University of Toronto, Toronto, ON, Canada (Prof. M. Andrew, Supervisor: Dr. Anthony Chan)
1999-2000: «Research fellow», Paediatric Thrombophilia Program, Hamilton Civic Hospitals Research Centre, McMaster University, Hamilton, ON, Canada (Prof. Maureen Andrew, Supervisor: Dr. Anthony Chan)
- since 2020: Editorial Board members of peer-reviewed Journal «Children»
- 2017-2020: Co-Chairman of the Scientific and Standardization Subcommittee (SSC) on Pediatric and Neonatal Thrombosis and Haemostasis of the International Society on Thrombosis and Haemostasis (ISTH)
- 2014-2020: President of the Swiss Hemophilia Network
- 2013-2020: Member of Paediatric Expert Working Group for the Pediatric Investigation Plan of the new oral anticoagulant, dabigatran etexilate, approved by EMA
- 2010-2020: Member of the faculty department «Frau und Kind», University of Zurich
- 2007-2020: Medical Board of the Swiss Hemophilia Society
- Since 2019: Vice Chairman of the Hemophilia Certification Committee of the GTH
- Since 2019: Board member of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung)
- 2013-2017: Chair of the working group on catheter-related arterial thrombosis from the Scientific and Standardization Committee (SSC) on Perinatal/Pediatric Haemostasis of the International Society on Thrombosis and Haemostasis (ISTH)
- since 2015: Member of the Steering Committee for the Pediatric Investigation Plan of the new oral anticoagulant, Edoxaban
- 2006-2015: Critical Incident Monitoring, University Children’s Hospital, Zurich, Switzerland
- 2012-2015: Member of the Data Monitoring Committee for a pediatric Phase I study on the new oral anticoagulant, rivaroxaban
- since 2009: Chair of the executive committee of Paediatric Outpatient Clinic, University Children’s Hospital, Zurich, Switzerland
- International Society on Thrombosis and Haemostasis (ISTH)
- Scientific and Standardization Committee (SSC) on Perinatal/Pediatric Haemostasis of the ISTH
- Swiss Haemophilia Network
- Gesellschaft für Thrombose und Haemostase Forschung (GTH)
- Swiss Society of Paediatrics (SGP)
- Verbindung der Schweizer Ärztinnen und Ärzte (FMH)
- World Federation of Hemophilia (WFH)